The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT

BACKGROUND: Intravenous thrombolysis (IVT) with (recombinant) tissue plasminogen activator is an effective treatment in acute ischemic stroke. However, IVT is contraindicated when blood pressure is above 185/110 mmHg, because of an increased risk on symptomatic intracranial hemorrhage. In current Du...

Descripción completa

Detalles Bibliográficos
Autores principales: Zonneveld, T. P., Algra, A., Dippel, D. W. J., Kappelle, L. J., van Oostenbrugge, R. J., Roos, Y. B. W. E. M., Wermer, M. J., van der Worp, H. B., Nederkoorn, P. J., Kruyt, N. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657238/
https://www.ncbi.nlm.nih.gov/pubmed/26596237
http://dx.doi.org/10.1186/s12883-015-0493-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657238/
https://www.ncbi.nlm.nih.gov/pubmed/26596237
http://dx.doi.org/10.1186/s12883-015-0493-z

Ejemplares similares